Aminophenols/therapeutic use; Aminopyridines/therapeutic use; Benzodioxoles/therapeutic use; Cystic Fibrosis/drug therapy; Membrane Transport Modulators/therapeutic use; Quinolones/therapeutic use; Administration, Oral; Aminophenols/administration & dosage; Aminophenols/adverse effects; Aminophenols/economics; Aminophenols/pharmacokinetics; Aminopyridines/administration & dosage; Aminopyridines/adverse effects; Aminopyridines/economics; Aminopyridines/pharmacokinetics; Benzodioxoles/administration & dosage; Benzodioxoles/adverse effects; Benzodioxoles/economics; Benzodioxoles/pharmacokinetics; Cystic Fibrosis/diagnosis; Cystic Fibrosis/economics; Cystic Fibrosis/genetics; Cystic Fibrosis Transmembrane Conductance Regulator/drug effects; Cystic Fibrosis Transmembrane Conductance Regulator/genetics; Drug Combinations; Drug Costs; Drug Interactions; Humans; Membrane Transport Modulators/administration & dosage; Membrane Transport Modulators/adverse effects; Membrane Transport Modulators/economics; Membrane Transport Modulators/pharmacokinetics; Mutation; Quinolones/administration & dosage; Quinolones/adverse effects; Quinolones/economics; Quinolones/pharmacokinetics; Risk Factors; Treatment Outcome